Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

Anders, 2010, Differential expression analysis for sequence count data, Genome Biol., 11, R106, 10.1186/gb-2010-11-10-r106 Anders, 2013, Count-based differential expression analysis of RNA sequencing data using R and Bioconductor, Nat. Protoc., 8, 1765, 10.1038/nprot.2013.099 Anders, 2015, HTSeq—a Python framework to work with high-throughput sequencing data, Bioinformatics, 31, 166, 10.1093/bioinformatics/btu638 Ben-Porath, 2008, An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors, Nat. Genet., 40, 499, 10.1038/ng.127 Bock, 2011, Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines, Cell, 144, 439, 10.1016/j.cell.2010.12.032 Brewer, 2009, Embryonic vaccines against cancer: an early history, Exp. Mol. Pathol., 86, 192, 10.1016/j.yexmp.2008.12.002 Bruggner, 2014, Automated identification of stratifying signatures in cellular subpopulations, Proc. Natl. Acad. Sci. USA, 111, E2770, 10.1073/pnas.1408792111 Chang, 2014, High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cells, Cell Res., 24, 293, 10.1038/cr.2013.173 Chen, 2011, A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways, Cancer Res., 71, 473, 10.1158/0008-5472.CAN-10-1303 Chung, 2013, An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy, Nat. Med., 19, 1114, 10.1038/nm.3291 Churko, 2017, Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods, Nat. Biomed. Eng., 1, 826, 10.1038/s41551-017-0141-6 Consortium, 2011, A user’s guide to the encyclopedia of DNA elements (ENCODE), PLoS Biol., 9, e1001046, 10.1371/journal.pbio.1001046 de Almeida, 2014, Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance, Nat. Commun., 5, 3903, 10.1038/ncomms4903 Diecke, 2015, Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency, Sci. Rep., 5, 8081, 10.1038/srep08081 Dolcetti, 2010, Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF, Eur. J. Immunol., 40, 22, 10.1002/eji.200939903 Dooms, 2002, Life and death in effector T cells, Nat. Immunol., 3, 797, 10.1038/ni0902-797 Evans, 2014, A synthetic luciferin improves bioluminescence imaging in live mice, Nat. Methods, 11, 393, 10.1038/nmeth.2839 Gajewski, 2013, Innate and adaptive immune cells in the tumor microenvironment, Nat. Immunol., 14, 1014, 10.1038/ni.2703 Galvan, 2015, Anti-tumor effects after adoptive transfer of IL-12 transposon-modified murine splenocytes in the OT-I-melanoma mouse Model, PLoS ONE, 10, e0140744, 10.1371/journal.pone.0140744 Ghosh, 2011, Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells, Cancer Res., 71, 5030, 10.1158/0008-5472.CAN-10-4402 Gilkeson, 1998, Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice, J. Immunol., 161, 3890, 10.4049/jimmunol.161.8.3890 Goldstein, 2011, A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors, Blood, 117, 118, 10.1182/blood-2010-06-288456 Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, N. Engl. J. Med., 368, 1509, 10.1056/NEJMoa1215134 Harrow, 2012, GENCODE: the reference human genome annotation for The ENCODE Project, Genome Res., 22, 1760, 10.1101/gr.135350.111 He, 2010, IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells, J. Immunol., 184, 2281, 10.4049/jimmunol.0902574 Inoue, 2013, Vaccination With Irradiated Induced Pluripotent Stem Cells Genetically Engineered To Produce GM-CSF Confers Potent T Cells-Mediated Antitumor Immunity, Blood, 122, 4492, 10.1182/blood.V122.21.4492.4492 Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 Kocatürk, 2015, Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth, J. Vis. Exp., 96, 51967 Kooreman, 2010, Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging, J. R. Soc. Interface, 7, S753 Le, 2015, PD-1 blockade in tumors with mismatch-repair deficiency, N. Engl. J. Med., 372, 2509, 10.1056/NEJMoa1500596 Lee, 2013, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, Nat. Med., 19, 998, 10.1038/nm.3267 Lee, 2015, T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial, Lancet, 385, 517, 10.1016/S0140-6736(14)61403-3 Li, 2009, Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer, Stem Cells, 27, 3103, 10.1002/stem.234 Mallon, 2013, StemCellDB: the human pluripotent stem cell database at the National Institutes of Health, Stem Cell Res. (Amst.), 10, 57, 10.1016/j.scr.2012.09.002 Mallon, 2014, Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin, Stem Cell Res. (Amst.), 12, 376, 10.1016/j.scr.2013.11.010 Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N. Engl. J. Med., 371, 1507, 10.1056/NEJMoa1407222 Maus, 2014, Antibody-modified T cells: CARs take the front seat for hematologic malignancies, Blood, 123, 2625, 10.1182/blood-2013-11-492231 Mestas, 2004, Of mice and not men: differences between mouse and human immunology, J. Immunol., 172, 2731, 10.4049/jimmunol.172.5.2731 Mor, 1997, Do DNA vaccines induce autoimmune disease?, Hum. Gene Ther., 8, 293, 10.1089/hum.1997.8.3-293 Morgan, 2010, Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2, Mol. Ther., 18, 843, 10.1038/mt.2010.24 Mukherjee, 2007, MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model, Vaccine, 25, 1607, 10.1016/j.vaccine.2006.11.007 Naas, 2010, Adoptive transfer of splenocytes to study cell-mediated immune responses in hepatitis C infection using HCV transgenic mice, Comp. Hepatol., 9, 7, 10.1186/1476-5926-9-7 Nelakanti, 2015, Teratoma formation: a tool for monitoring pluripotency in stem cell research, Curr. Protoc. Stem Cell Biol., 32, 10.1002/9780470151808.sc04a08s32 Numasaki, 2003, Interleukin-17 promotes angiogenesis and tumor growth, Blood, 101, 2620, 10.1182/blood-2002-05-1461 Palena, 2006, Cancer vaccines: preclinical studies and novel strategies, Adv. Cancer Res., 95, 115, 10.1016/S0065-230X(06)95004-0 Qiu, 2011, Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE, Nat. Biotechnol., 29, 886, 10.1038/nbt.1991 Sodhi, 1985, Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells, Arch. Geschwulstforsch., 55, 47 Soldner, 2009, Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors, Cell, 136, 964, 10.1016/j.cell.2009.02.013 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Torcellan, 2017, In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors, Proc. Natl. Acad. Sci. USA, 114, 5677, 10.1073/pnas.1618446114 Yaddanapudi, 2012, Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?, PLoS ONE, 7, e42289, 10.1371/journal.pone.0042289 Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 Zou, 2005, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nat. Rev. Cancer, 5, 263, 10.1038/nrc1586